Author

Wafa Al-Santli

NYU Langone’s Laura and Isaac Perlmutter Cancer CenterORCID 0009-0001-6332-8789Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Adrienne Heyrosa· 1 shared Alan H. ShihiD· 1 shared Alice S. MimsiD· 1 shared Andrea LagansoniD· 1 shared Ann‐Kathrin EisfeldiD· 1 shared Aristotelis TsirigosiD· 1 shared Arwa Shana’ahiD· 1 shared Audrey LasryiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrienne Heyrosa

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 5, 2025

Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcoma

Bettina Nadorp, Audrey Lasry, Sanam Loghavi…·Ann‐Kathrin Eisfeld

This study characterizes myeloid sarcoma through multi-omic profiling, identifies RAS pathway activation as a hallmark, and shows RAS inhibition reduces tumor burden in mouse models.

DOI 10.64898/2025.12.04.689069

mousebulk RNA-seq

𝕏 PostBluesky